Ocular Therapeutix (NasdaqGM:OCUL) Conference Transcript

Ocular Therapeutix (NasdaqGM:OCUL) Conference March 25, 2026 09:30 AM ET Company ParticipantsLisa Walter - VP of Biotech Equity ResearchPravin Dugel - Executive Chairman, President, and CEOLisa WalterGood morning, everyone. I'm Lisa Walter, Biotech Analyst here at RBC Capital Markets. Thanks for joining us at RBC's Ophthalmology Conference. This session, we have Pravin Dugel, Executive Chairman, President, and CEO of Ocular Therapeutix. Pravin, thanks so much for joining us today. How are you doing?Pravin D ...